Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 4/20 | 0.66 |
| ▸ | CHRNA7 | P36544 | 5/20 | 0.63 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7876242 | 0.92 | CA9 (0.66) | CA9CHRNA7NR1H2PTGS2SMN1; SMN2 | |
| SCHEMBL7878961 | 0.89 | CA9 (0.62) | CA9CHRNA7NR1H2PTGS2SMN1; SMN2 | |
| SCHEMBL6511261 | 0.89 | CA9 (0.69) | CA9CHRNA7PTGS2SMN1; SMN2HDAC3 | |
| SCHEMBL7872897 | 0.88 | CHRNA7 (0.66) | CA9CHRNA7NR1H2PTGS2SMN1; SMN2 | |
| SCHEMBL7872741 | 0.88 | CHRNA7 (0.66) | CA9CHRNA7NR1H2PTGS2SMN1; SMN2 | |
| SCHEMBL9204895 | 0.86 | CA9 (0.82) | CA9CHRNA7NR1H2PTGS2SMN1; SMN2 | |
| SCHEMBL7874469 | 0.86 | CHRNA7 (0.66) | CA9CHRNA7NR1H2PTGS2SMN1; SMN2 | |
| SCHEMBL7872745 | 0.86 | CHRNA7 (0.66) | CA9CHRNA7NR1H2PTGS2SMN1; SMN2 | |
| SCHEMBL7627415 | 0.85 | CHRNA7 (0.83) | CA9CHRNA7PTGS2 | |
| SCHEMBL9199282 | 0.85 | CA9 (0.72) | CA9CHRNA7NR1H2PTGS2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6316485-B1 | INHIBITS ACTIVITY OF CYCLOOXYGENASE-2; FOR THERAPY AND PROPHYLAXIS OF INFLAMMATION, THROMBOSIS, RHEUMATOID ARTHRITIS, ALZHEIMER'S DISEASE; AS ANALGESIC | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-11-13 | — | — | US | disclosed |
| EP-1017678-A1 | 1,5-DIPHENYLPYRAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-07-12 | — | — | EP | disclosed |
| WO-1999015505-A1 | 1,5-DIPHENYLPYRAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-04-01 | — | — | WO | disclosed |